Webber Matthew J, Khan Omar F, Sydlik Stefanie A, Tang Benjamin C, Langer Robert
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Room 76-661, Cambridge, MA, 02139, USA.
Ann Biomed Eng. 2015 Mar;43(3):641-56. doi: 10.1007/s10439-014-1104-7. Epub 2014 Sep 9.
Scaffolds have been broadly applied within tissue engineering and regenerative medicine to regenerate, replace, or augment diseased or damaged tissue. For a scaffold to perform optimally, several design considerations must be addressed, with an eye toward the eventual form, function, and tissue site. The chemical and mechanical properties of the scaffold must be tuned to optimize the interaction with cells and surrounding tissues. For complex tissue engineering, mass transport limitations, vascularization, and host tissue integration are important considerations. As the tissue architecture to be replaced becomes more complex and hierarchical, scaffold design must also match this complexity to recapitulate a functioning tissue. We outline these design constraints and highlight creative and emerging strategies to overcome limitations and modulate scaffold properties for optimal regeneration. We also highlight some of the most advanced strategies that have seen clinical application and discuss the hurdles that must be overcome for clinical use and commercialization of tissue engineering technologies. Finally, we provide a perspective on the future of scaffolds as a functional contributor to advancing tissue engineering and regenerative medicine.
支架已在组织工程和再生医学中得到广泛应用,以再生、替代或增强患病或受损组织。为使支架发挥最佳性能,必须考虑几个设计因素,着眼于最终的形态、功能和组织部位。必须调整支架的化学和机械性能,以优化与细胞和周围组织的相互作用。对于复杂的组织工程,传质限制、血管化和宿主组织整合是重要的考虑因素。随着要替代的组织结构变得更加复杂和分层,支架设计也必须匹配这种复杂性,以重现功能正常的组织。我们概述了这些设计限制,并强调了创新和新兴策略,以克服限制并调节支架性能以实现最佳再生。我们还强调了一些已应用于临床的最先进策略,并讨论了组织工程技术临床应用和商业化必须克服的障碍。最后,我们展望了支架作为推动组织工程和再生医学发展的功能性贡献者的未来。